Literature DB >> 26313239

Effect of vaccine administration modality on immunogenicity and efficacy.

Lu Zhang1,2, Wei Wang3, Shixia Wang4.   

Abstract

The many factors impacting the efficacy of a vaccine can be broadly divided into three categories: features of the vaccine itself, including immunogen design, vaccine type, formulation, adjuvant and dosing; individual variations among vaccine recipients and vaccine administration-related parameters. While much literature exists related to vaccines, and recently systems biology has started to dissect the impact of individual subject variation on vaccine efficacy, few studies have focused on the role of vaccine administration-related parameters on vaccine efficacy. Parenteral and mucosal vaccinations are traditional approaches for licensed vaccines; novel vaccine delivery approaches, including needless injection and adjuvant formulations, are being developed to further improve vaccine safety and efficacy. This review provides a brief summary of vaccine administration-related factors, including vaccination approach, delivery route and method of administration, to gain a better understanding of their potential impact on the safety and immunogenicity of candidate vaccines.

Entities:  

Keywords:  administration; efficacy; immunogenicity; vaccination; vaccine; vaccine delivery

Mesh:

Substances:

Year:  2015        PMID: 26313239      PMCID: PMC4915566          DOI: 10.1586/14760584.2015.1081067

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  174 in total

1.  Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.

Authors:  H Asanuma; K Hirokawa; M Uchiyama; Y Suzuki; C Aizawa; T Kurata; T Sata; S Tamura
Journal:  Vaccine       Date:  2001-07-16       Impact factor: 3.641

2.  Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection.

Authors:  Daisuke Ikeno; Kazuhiko Kimachi; Yoichiro Kino; Seiichi Harada; Kayo Yoshida; Shinji Tochihara; Shigeyuki Itamura; Takato Odagiri; Masato Tashiro; Kenji Okada; Chiaki Miyazaki; Kohji Ueda
Journal:  Microbiol Immunol       Date:  2010-02       Impact factor: 1.955

Review 3.  Vaccine adjuvant formulations: a pharmaceutical perspective.

Authors:  Luis A Brito; Padma Malyala; Derek T O'Hagan
Journal:  Semin Immunol       Date:  2013-07-12       Impact factor: 11.130

4.  Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Authors:  Joanne Huang; John A Mikszta; Matthew S Ferriter; Ge Jiang; Noel G Harvey; Beverly Dyas; Chad J Roy; Robert G Ulrich; Vincent J Sullivan
Journal:  Hum Vaccin       Date:  2007-05-13

5.  A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.

Authors:  A F Charest; J McDougall; M B Goldstein
Journal:  Am J Kidney Dis       Date:  2000-11       Impact factor: 8.860

6.  Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants.

Authors:  Hee-Jeong Cho; Ji-Yeon Kim; Young Lee; Jung Mogg Kim; Young Bong Kim; Taehoon Chun; Yu-Kyoung Oh
Journal:  Vaccine       Date:  2010-01-28       Impact factor: 3.641

7.  A prime-boost vaccination of mice with heterologous H5N1 strains.

Authors:  Daisuke Ikeno; Kazuhiko Kimachi; Yasuhiro Kudo; Shuro Goto; Shigeyuki Itamura; Takato Odagiri; Masato Tashiro; Yoichiro Kino
Journal:  Vaccine       Date:  2009-05-18       Impact factor: 3.641

8.  Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery.

Authors:  Grace Ledet; Sarala Pamujula; Valencia Walker; Shana Simon; Richard Graves; Tarun K Mandal
Journal:  Drug Dev Ind Pharm       Date:  2013-04-19       Impact factor: 3.225

Review 9.  Immunity to viruses: learning from successful human vaccines.

Authors:  Bali Pulendran; Jason Z Oh; Helder I Nakaya; Rajesh Ravindran; Dmitri A Kazmin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 10.  Transcutaneous antigen delivery system.

Authors:  Mi-Young Lee; Meong-Cheol Shin; Victor C Yang
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

View more
  60 in total

1.  Multiantigenic Nanotoxoids for Antivirulence Vaccination against Antibiotic-Resistant Gram-Negative Bacteria.

Authors:  Xiaoli Wei; Danni Ran; Anaamika Campeau; Crystal Xiao; Jiarong Zhou; Diana Dehaini; Yao Jiang; Ashley V Kroll; Qiangzhe Zhang; Weiwei Gao; David J Gonzalez; Ronnie H Fang; Liangfang Zhang
Journal:  Nano Lett       Date:  2019-06-11       Impact factor: 11.189

2.  Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya.

Authors:  M Oneko; Y R Cherop; T Sang; J R Gutman; R Wiegand; E M Nyang'au; A D Odila; D Akach; M J Hamel; A M Samuels; S Kariuki; Y Abebe; E L Nzuu; W Wijayalath; E R James; B K L Sim; P F Billingsley; T L Richie; S L Hoffman; R A Seder; L C Steinhardt
Journal:  Vaccine       Date:  2020-05-19       Impact factor: 3.641

3.  Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice.

Authors:  Kyle Caution; Kacy Yount; Rajendar Deora; Purnima Dubey
Journal:  J Vis Exp       Date:  2019-02-22       Impact factor: 1.355

4.  BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis.

Authors:  Sangeeta Tiwari; Taru S Dutt; Bing Chen; Mei Chen; John Kim; Annie Zhi Dai; Regy Lukose; Crystal Shanley; Amy Fox; Burton R Karger; Steven A Porcelli; John Chan; Brendan K Podell; Andres Obregon-Henao; Ian M Orme; William R Jacobs; Marcela Henao-Tamayo
Journal:  Vaccine       Date:  2020-09-23       Impact factor: 3.641

5.  Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity.

Authors:  Sebastian Ols; Lifei Yang; Elizabeth A Thompson; Pradeepa Pushparaj; Karen Tran; Frank Liang; Ang Lin; Bengt Eriksson; Gunilla B Karlsson Hedestam; Richard T Wyatt; Karin Loré
Journal:  Cell Rep       Date:  2020-03-24       Impact factor: 9.423

6.  Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses.

Authors:  Emad I Wafa; Sean M Geary; Kathleen A Ross; Jonathan T Goodman; Balaji Narasimhan; Aliasger K Salem
Journal:  J Pharmacol Exp Ther       Date:  2018-10-25       Impact factor: 4.030

Review 7.  Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities.

Authors:  Colby S Shemesh; Joy C Hsu; Iraj Hosseini; Ben-Quan Shen; Anand Rotte; Patrick Twomey; Sandhya Girish; Benjamin Wu
Journal:  Mol Ther       Date:  2020-09-30       Impact factor: 11.454

8.  Microparticle Depots for Controlled and Sustained Release of Endosomolytic Nanoparticles.

Authors:  Kyle M Garland; Sema Sevimli; Kameron V Kilchrist; Craig L Duvall; Rebecca S Cook; John T Wilson
Journal:  Cell Mol Bioeng       Date:  2019-05-03       Impact factor: 2.321

9.  An Outer Membrane Vesicle-Adjuvanted Oral Vaccine Protects Against Lethal, Oral Salmonella Infection.

Authors:  Jaikin E Harrell; Jonathan R Kurtz; David L Bauer; J Timothy Prior; Patrick S Gellings; Lisa A Morici; James B McLachlan
Journal:  Pathogens       Date:  2021-05-18

Review 10.  Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines.

Authors:  Lu Han; Ke Peng; Li-Ying Qiu; Meng Li; Jing-Hua Ruan; Li-Li He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.